Isolation of different species of candida in patients with vulvovaginal candidiasis from Damavand, Iran

Archives of Clinical Infectious Diseases

Volumn 13, Issue 6, 2018, Pages

  Ghajari, Ali ^a   Lotfali, Ensieh ^a   Ahmadi, Nayeb Ali ^b   Fassihi, Parvin Nazer ^c   Shahmohammadi, Nasrin ^a   Ansari, Saham ^a   Norouzi, Maryam ^a   Arab Mazar, Zahra ^d,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candida sp; Iran; Vulvovaginal Candidiasis

Indexed keywords

INTERNAL TRANSCRIBED SPACER; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; IRAN; IRANIAN PEOPLE; KLUYVEROMYCES MARXIANUS; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; SPECIES IDENTIFICATION; VAGINA CANDIDIASIS;

EID: 85057750552     PISSN: 23452641     EISSN: 20081081     Source Type: Journal    
DOI: 10.5812/archcid.59291     Document Type: Article

References (43)

1. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152(7):924–35. doi: 10.1016/s0002-9378(85)80003-x.
2. Kubota T. Chronic and recurrent vulvovaginal candidiasis. Nippon Ishinkin Gakkai Zasshi. 1998;39(4):213–8. doi: 10.3314/jjmm.39.213.
3. Yucesoy M, Marol S. Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob. 2003;2:8. doi: 10.1186/1476-0711-2-8. [PubMed: 14613587]. [PubMed Central: PMC280667].
4. Sendid B, Francois N, Standaert A, Dehecq E, Zerimech F, Camus D, et al. Prospective evaluation of the new chromogenic medium CandiSe-lect 4 for differentiation and presumptive identification of the major pathogenic Candida species. J Med Microbiol. 2007;56(Pt 4):495–9. doi: 10.1099/jmm.0.46715-0. [PubMed: 17374890].
5. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol. 1993;36(1):153– 65. [PubMed: 8435940].
6. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol. 1981;24(2):407–38. [PubMed: 7307366].
7. Spinillo A, Capuzzo E, Egbe T, Baltaro F, Nicola S, Piazzi G. Vaginitis. Obstet Gynecol. 1995;85(6):993–8. doi: 10.1016/0029-7844(95)00047-u.
8. Quan M. Vaginitis: Diagnosis and management. Postgrad Med. 2010;122(6):117–27. doi: 10.3810/pgm.2010.11.2229. [PubMed: 21084788].
9. Trama JP, Adelson ME, Raphaelli I, Stemmer SM, Mordechai E. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol. 2005;13(2):63–7. doi: 10.1080/10647440400025629. [PubMed: 16011995]. [PubMed Central: PMC1784561].
10. Jamilian M, Mashhadi E, Sarmadi F, Ghaznavirad A, Bani J, Farhadi E, et al. Frequancy of vulvovaginal candidiasis species in nonpreg-nant 15-50 years old women in spring 2005 in Arak. Arak Med Univ J. 2007;10(2):7–14.
11. Etminan S, Zarinkatsh H, Lotfee M. [The prevalence of Candida vaginitis among women aged 15-49 years in Yazd, Iran]. Med Lab J. 2008;2(1):0. Persian.
12. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155– 62. doi: 10.1128/JCM.43.5.2155-2162.2005. [PubMed: 15872235]. [PubMed Central: PMC1153777].
13. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997;24(6):1122–8. [PubMed: 9195068].
14. Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulop-sis) glabrata. J Clin Microbiol. 1996;34(1):58–61. [PubMed: 8748273]. [PubMed Central: PMC228730].
15. Berek JS, Adashi EY, Hillard PA. Novak’s gynecology. Williams and Wilkins; 1996.
16. Willinger B, Manafi M. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses. 1999;42(1-2):61–5. [PubMed: 10394850].
17. Verghese S, Padmaja P, Asha M, Elizabeth SJ, Anitha A, Kundavi KM, et al. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women. Indian J Pathol Microbiol. 2001;44(3):313– 4. [PubMed: 12024920].
18. Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Yazdani Cherati J, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbiol. 2015;8(4). e15992. doi: 10.5812/jjm.8(4)2015.15992. [PubMed: 26034533]. [PubMed Central: PMC4449843].
19. Rezaei-Matehkolaei A, Shafiei S, Zarei-Mahmoudabadi A. Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species. Iran J Microbiol. 2016;8(6):410–7. [PubMed: 28491253]. [PubMed Central: PMC5420397].
20. Makimura K, Tamura Y, Mochizuki T, Hasegawa A, Tajiri Y, Hanazawa R, et al. Phylogenetic classification and species identification of der-matophyte strains based on DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Clin Microbiol. 1999;37(4):920–4. [PubMed: 10074502]. [PubMed Central: PMC88625].
21. Ghahri M, Mirhendi H, Zomorodian K, Kondori N. Identification and antifungal susceptibility patterns of Candida strains isolated from blood specimens in Iran. Arch Clin Infect Dis. 2013;8(3). doi: 10.5812/archcid.14529.
22. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137. [PubMed: 26042815]. [PubMed Central: PMC5885289].
23. Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):199–203. doi: 10.1016/j.ejogrb.2010.11.022. [PubMed: 21194828].
24. Aalei B, Touhidi A. [Prevalence of Candida vaginits among symptomatic patients in Kerman]. J Qazvin Univ Med Sci. 2000;(13):42–8. Persian.
25. Karmastaji A, Khajeh F, Amirian M. [Comparison between clinical and laboratory diagnosis of vaginitis]. Med J Hormozgan Univ. 2005;9(2):131–6. Persian.
26. Farrell SM, Hawkins DF, Ryder TA. Scanning electron microscope study of Candida albicans invasion of cultured human cervical epithelial cells. Sabouraudia. 1983;21(3):251–4. [PubMed: 6356411].
27. Powell BL, Drutz DJ. Confirmation of corticosterone and progesterone binding activity in Candida albicans. J Infect Dis. 1983;147(2):359. [PubMed: 6338133].
28. Sobel JD, Muller G, McCormick JF. Experimental chronic vaginal can-didosis in rats. Sabouraudia. 1985;23(3):199–206. [PubMed: 4023886].
29. Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 2006;2(12). e129. doi: 10.1371/jour-nal.ppat.0020129. [PubMed: 17196036]. [PubMed Central: PMC1757199].
30. Sobel JD, Muller G, Buckley HR. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun. 1984;44(3):576– 80. [PubMed: 6327527]. [PubMed Central: PMC263631].
31. Zhu W, Filler SG. Interactions of Candida albicans with epithelial cells. Cell Microbiol. 2010;12(3):273–82. doi: 10.1111/j.1462-5822.2009.01412.x. [PubMed: 19919567]. [PubMed Central: PMC3383095].
32. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178(2):203–11. doi: 10.1016/s0002-9378(98)80001-x.
33. Merson-Davies LA, Odds FC, Malet R, Young S, Riley V, Schober P, et al. Quantification of Candida albicans morphology in vaginal smears. Eur J Obstet Gynecol Reprod Biol. 1991;42(1):49–52. doi: 10.1016/0028-2243(91)90159-i.
34. Zhou X, Westman R, Hickey R, Hansmann MA, Kennedy C, Osborn TW, et al. Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun. 2009;77(9):4130–5. doi: 10.1128/IAI.00436-09. [PubMed: 19528218]. [PubMed Central: PMC2738030].
35. Torabi M, Amini B. The relation of health behavior with vaginal infection in woman referred to family planning clinics of Zanjan. Zanjan J Med Sci. 1996;21:49–4.
36. Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009;144(1):68–71. doi: 10.1016/j.ejogrb.2008.12.020. [PubMed: 19261369].
37. Kennedy MA, Sobel JD. Vulvovaginal candidiasis caused by non-albicans Candida species: New insights. Curr Infect Dis Rep. 2010;12(6):465–70. doi: 10.1007/s11908-010-0137-9. [PubMed: 21308556].
38. Gumral R, Sancak B, Guzel AB, Saracli MA, Ilkit M. Lack of Candida africana and Candida dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms. Mycopathologia. 2011;172(1):73–6. doi: 10.1007/s11046-011-9401-2. [PubMed: 21380767].
39. Bonyadpour B, Akbarzdeh M, Pakshir K, Mohagheghzadeh AA. [In vitro susceptibility of fluconazole, clotrimazole and toucrium polium smoke product on Candida isolates of vaginal candidiasis]. Armaghane Danesh. 2009;14(2):87–96. Persian.
40. Adesiji Y, Ndukwe N, Okanlawon B. Isolation and antifungal sensitivity to Candida isolates in young females. Open Medicine. 2011;6(2). doi: 10.2478/s11536-010-0071-0.
41. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trend Microbiol. 2001;9(7):327–35. doi: 10.1016/s0966-842x(01)02094-7.
42. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol. 2005;8(4):378–84. doi: 10.1016/j.mib.2005.06.012. [PubMed: 15996895].
43. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253–73. doi: 10.1128/CMR.00076-09. [PubMed: 20375352]. [PubMed Central: PMC2863365].